Post Resch Tallon Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Post Resch Tallon Group's PFE Position: Q3 2026 in Review
Post Resch Tallon Group increased its Pfizer (PFE) stake by 5.7% in Q3 2026, buying an estimated $46.6K and bringing the position to 32,293 shares worth $921K. The position accounts for 0.63% of the portfolio, ranked #35.
Post Resch Tallon Group first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Post Resch Tallon Group held 32,293 shares of Pfizer worth $921K as of Q3 2026.
- Post Resch Tallon Group bought 1,751 Pfizer shares in Q3 2026, an estimated $46.6K.
- Pfizer made up 0.63% of Post Resch Tallon Group's portfolio in Q3 2026, its #35 holding.
- Post Resch Tallon Group first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Post Resch Tallon Group's 13F filing for Q3 2026, filed 9 Oct 2026.